ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO280

Mortality of Elderly Patients with AKI Undergoing Continuous Renal Replacement Therapy: Is Age a Risk Factor?

Session Information

Category: Dialysis

  • 801 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Yoon, Jeeyoung, The Catholic University of Korea, College of Medicine, Seoul, Korea (the Republic of)
  • Min, Ji Won, Bucheon St. Mary's Hospital, Bucheon, Korea (the Republic of)
  • Koh, Eun Sil, Yeouido St. Mary's Hospital, Seoul, Korea (the Republic of)
  • Ko, Eun jeong, Bucheon St. Mary's Hospital, Bucheon, Korea (the Republic of)
  • Kim, Hyung Duk, Eunpyeong St. Mary's Hospital, Seoul, Korea (the Republic of)
  • Chung, Byung ha, Seoul St. Mary's Hospital, Seoul, Korea (the Republic of)
  • Shin, Seok Joon, Incheon St. Mary's Hospital, Incheon, Korea (the Republic of)
  • Yoon, Hye Eun, Incheon St. Mary's Hospital, Incheon, Korea (the Republic of)
  • Eum, Sang Hun, Incheon St. Mary's Hospital, Incheon, Korea (the Republic of)
Background

The incidence of elderly patients with acute kidney injury (AKI) requiring continuous renal replacement therapy (CRRT) is increasing. There is little evidence on the difference of mortality rates according to age in elderly patients. This study aimed to evaluate the age effect and predictors for mortality in elderly patients with AKI requiring CRRT.

Methods

A retrospective analysis was performed in elderly patients with AKI who underwent CRRT. A total of 480 patients aged ≥65 years were stratified into three groups according to age: youngest-old (age 65-74 years, n=205), middle-old (age 75-84 years, n=217), and oldest-old (age ≥85 years, n=58). The 28-day and 90-day survival rates were compared between three groups and predictors for mortality were analysed.

Results

The 28-day and 90-day survival rates were not different between three age groups (P=0.156 and P=0.189, respectively). The oldest-old group did not show an inferior survival rate to other two groups. For 28-day mortality, prothrombin time [hazard ratio (HR) = 1.37, 95% confidence interval (CI) = 1.01 – 1.88, P = 0.046] and urine output at the start of CRRT (HR = 0.999, 95% CI = 0.998 – 1.000, P=0.012) and CRRT duration (HR = 0.89, 95% CI = 0.83 – 0.95, P=0.001) were predictors. For 90-day mortality, mean arterial pressure (HR = 1.02, 95% CI = 1.00 – 1.05, P=0.019), admission duration (HR = 0.97, 95% CI = 0.95 – 0.99, P<0.001) and CRRT duration (HR = 0.96, 95% CI = 0.91 – 0.99, P=0.036) were predictors. The middle-old group or the oldest-old group did not exhibit higher risk compared to the youngest-old group for 28-day and 90-day mortality.

Conclusion

An older age was not a risk factor for mortality in elderly patients with AKI undergoing CRRT. This implicates the importance of active management and application of CRRT in critically ill elderly patients with AKI.